KMY Tablets Safety Study in Healthy Adults
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 45 years old.
- Your body mass index (a measure based on height and weight) is between 19 and 26.
- You weigh at least 110 pounds if male, or 99 pounds if female.
- You are generally healthy with no major medical conditions.
- You agree to use effective birth control during the study and for a time after.
- You have not used any medications (including over-the-counter or herbals) or health supplements in the 2 weeks before screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
This study tests a new medicine called KHN702 in healthy volunteers to see how the body processes it and whether it is safe. It is an early-stage trial, so participants will help find out how the drug works before it is studied in patients.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.